Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA) and Gain Therapeutics (NASDAQ:GANX).
Passage Bio has a consensus price target of $7.25.
The stock price for Passage Bio (NASDAQ: PASG) is $0.6994 last updated December 24, 2024 at 4:17 PM EST.
There are no upcoming dividends for Passage Bio.
Passage Bio’s Q4 earnings are confirmed for Monday, March 3, 2025.
There is no upcoming split for Passage Bio.
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.